RxDoctor Payments Data

Joshua Perry, PA

Physician Assistant · Rockingham, NCNPI 1043835796

Payments from drug & device makers

$1,871in general payments, 2019–2025

Across 63 payments — averaging $29.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$342
  • SPR Therapeutics, Inc$320
  • Nevro Corp.$207
  • Collegium Pharmaceutical, Inc.$197
  • Boston Scientific$184
  • Curonix LLC$128
  • plus $494 from 12 others

What the payments were for

  • Food & beverage$1,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,871 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$44,533
Medicare patients
121
Services billed
675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl68$40,823
Buprenorphine162$38,866
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen577$22,640
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen538$14,321
Hysingla ErHydrocodone Bitartrate14$8,721
Naloxone Hcl108$7,070
Oxycodone Hcl278$3,735
Gabapentin398$3,696
Pregabalin177$3,241
Fentanyl18$2,535
Lidocaine13$2,431
Tramadol Hcl137$1,930
Tizanidine Hcl181$1,540
Baclofen86$949
Cyclobenzaprine Hcl107$891

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$197$40,82368 claims
Hikma Pharmaceuticals USABuprenorphine$16$38,866162 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Rockingham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →